Is Xeris Biopharma Holdings Inc (NASDAQ: XERS) Stock Set To Rise More?

In the last trading session, 1.77 million Xeris Biopharma Holdings Inc (NASDAQ:XERS) shares changed hands as the company’s beta touched 1.64. With the company’s per share price at $1.85 changed hands at -$0.06 or -3.14% during last session, the market valuation stood at $259.83M. XERS’s last price was a discount, traded about -76.22% off its 52-week high of $3.26. The share price had its 52-week low at $1.46, which suggests the last value was 21.08% up since then. When we look at Xeris Biopharma Holdings Inc’s average trading volume, we note the 3-month average coming to 1.99 million.

Xeris Biopharma Holdings Inc (NASDAQ:XERS) trade information

Instantly XERS was in red as seen at the end of in last trading. With action -8.42%, the performance over the past five days has been red. The drop to weekly highs of 2.0650 subtracted -3.14% to the stock’s daily price. The company’s shares are showing year-to-date downside of -21.28%, with the 5-day performance at -8.42% in the red. However, in the 30-day time frame, Xeris Biopharma Holdings Inc (NASDAQ:XERS) is -13.15% down.

Xeris Biopharma Holdings Inc (XERS) estimates and forecasts

Data shows that the Xeris Biopharma Holdings Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 17.09% over the past 6 months, a 15.56% in annual growth rate that is considerably higher than the industry average of 9.40%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 38.13%. The 2024 estimates are for Xeris Biopharma Holdings Inc earnings to increase by 23.17%.